Connor Clark & Lunn Investment Management Ltd. Takes $1.78 Million Position in Encompass Health Co. (NYSE:EHC)

Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 18,397 shares of the company's stock, valued at approximately $1,778,000.

Several other institutional investors and hedge funds also recently bought and sold shares of EHC. CIBC Asset Management Inc boosted its holdings in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock valued at $286,000 after buying an additional 100 shares in the last quarter. Commonwealth Equity Services LLC increased its position in Encompass Health by 1.3% during the 2nd quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock valued at $845,000 after buying an additional 123 shares in the last quarter. V Square Quantitative Management LLC raised its stake in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after buying an additional 140 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its holdings in Encompass Health by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company's stock worth $351,000 after acquiring an additional 160 shares in the last quarter. Finally, Verdence Capital Advisors LLC increased its holdings in shares of Encompass Health by 4.6% during the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company's stock valued at $355,000 after acquiring an additional 160 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Truist Financial reiterated a "buy" rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Stephens restated an "overweight" rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Royal Bank of Canada increased their price target on Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. Finally, UBS Group upped their price objective on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has a consensus rating of "Buy" and a consensus price target of $107.11.

Encompass Health Stock Performance

NYSE:EHC traded up $1.77 during mid-day trading on Tuesday, reaching $103.77. 546,807 shares of the stock were exchanged, compared to its average volume of 642,340. The company has a 50 day simple moving average of $97.28 and a 200-day simple moving average of $90.99. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $10.45 billion, a P/E ratio of 25.07, a P/E/G ratio of 1.34 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.33 billion. During the same period in the prior year, the company posted $0.86 EPS. The business's revenue for the quarter was up 11.9% on a year-over-year basis. Analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health's dividend payout ratio is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.